Work

Evaluating the limited impact of therapy with empagliflozin on primary PCI patients' outcomes: the ELITE-PCI trial

Year: 2025

Type: article

Study design: Clinical Trial

Source: Cardiovascular Biomedicine Journal

DOI: 10.18502/cbj.v5i1.19452

Authors: Abbas Andishmand, Seyed Mostafa Seyed Hossaini Tezerjani, Hasan Haghaninejad, Sara Amel Shahbaz, Seyed Mostafa Mousavi Nodoushan

Institution: Shahid Sadoughi University of Medical Sciences and Health Services

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413855867

FWCI:

Cites:

Cited by:

Related to: 10